Uppsala (Sweden) and Brasschaat (Belgium), May 25th 2020 - Uppsala Therapeutics and LFSCNC today announced that they have entered into a strategic collaboration agreement to further develop Uppsala’s unique technologies based on RNAi drugs and systems for delivery thro...
